data_2e72_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e72 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.731 0.3 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 377' ' ' CYS . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.455 ' N ' HG21 ' A' ' 376' ' ' ILE . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 394' ' ' MET . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.334 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 377' ' ' CYS . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.422 ' N ' HG23 ' A' ' 376' ' ' ILE . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.438 ' CG2' ' C ' ' A' ' 381' ' ' ASN . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.438 ' C ' ' CG2' ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 394' ' ' MET . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . 0.457 ' CG2' ' HB1' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.457 ' HB1' ' CG2' ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.459 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 22.1 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.704 0.288 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' CYS . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 388' ' ' GLU . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.763 0.316 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.432 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.472 ' N ' ' HE3' ' A' ' 375' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.71 0.29 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.457 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 380' ' ' CYS . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 388' ' ' GLU . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 387' ' ' THR . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 388' ' ' GLU . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 376' ' ' ILE . 13.4 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 377' ' ' CYS . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.466 HG21 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 394' ' ' MET . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.466 ' CD ' HG21 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 377' ' ' CYS . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.471 ' N ' HG21 ' A' ' 376' ' ' ILE . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 384' ' ' PHE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 388' ' ' GLU . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.475 ' N ' HG21 ' A' ' 387' ' ' THR . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 384' ' ' PHE . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.504 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.756 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 388' ' ' GLU . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.439 ' N ' HG21 ' A' ' 387' ' ' THR . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.486 ' CG2' ' C ' ' A' ' 381' ' ' ASN . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 381' ' ' ASN . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.486 ' C ' ' CG2' ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 394' ' ' MET . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 377' ' ' CYS . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.455 ' N ' HG23 ' A' ' 376' ' ' ILE . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 380' ' ' CYS . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 389' ' ' ALA . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 384' ' ' PHE . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.723 0.297 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 384' ' ' PHE . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.448 ' CD2' HD23 ' A' ' 390' ' ' LEU . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 50.6 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.753 0.311 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 381' ' ' ASN . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 380' ' ' CYS . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.746 0.307 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 377' ' ' CYS . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 391' ' ' ARG . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.443 ' N ' HG22 ' A' ' 376' ' ' ILE . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.534 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.534 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 394' ' ' MET . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.426 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.327 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.426 HG13 ' C ' ' A' ' 375' ' ' LYS . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 380' ' ' CYS . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 19.9 m -112.9 -59.15 2.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.9 t -56.15 131.79 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 122.52 -92.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.7 m -51.61 105.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.884 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 91.5 p -62.66 88.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 89.0 101.11 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -55.31 139.6 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.89 137.13 32.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -79.0 154.72 39.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 374' ' ' ARG . . . 55.07 52.86 44.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 373' ' ' GLY . 19.0 tpt180 -36.66 102.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.863 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp -98.37 111.94 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.455 HG21 ' N ' ' A' ' 377' ' ' CYS . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.455 ' N ' HG21 ' A' ' 376' ' ' ILE . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.552 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.552 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 394' ' ' MET . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -0.19 6.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -66.34 -65.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.401 ' SD ' ' CE ' ' A' ' 394' ' ' MET . 9.2 ttp -55.55 -58.13 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.3 t -38.96 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -138.36 125.57 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -157.17 144.04 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -71.94 109.02 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.959 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 74.5 p -110.12 -52.71 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 115.03 175.36 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.16 41.84 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.376 0.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 94.2 p -99.67 175.21 5.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 92.1 p -71.79 137.01 47.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 3.1 t -48.57 147.64 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -86.87 92.76 9.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -153.43 -177.18 26.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -66.77 -59.44 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 94.7 p -104.96 172.33 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 134.5 121.04 2.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -113.61 115.36 27.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.12 122.38 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -73.48 99.59 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -142.09 -51.99 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.422 ' C ' ' HD2' ' A' ' 375' ' ' LYS . 4.8 ptp85 -150.69 175.77 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.435 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -130.48 113.87 14.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 377' ' ' CYS . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.422 ' N ' HG23 ' A' ' 376' ' ' ILE . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -18.99 37.0 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.79 -44.34 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 32.8 mmm -89.63 46.08 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 403' ' ' GLU . 54.8 t -122.56 140.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 402' ' ' VAL . 53.9 mt-10 -57.9 -51.05 71.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -99.31 124.08 44.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.84 39.75 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -52.05 149.63 5.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.426 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -83.35 170.05 48.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 409' ' ' SER . 53.2 Cg_endo -69.78 178.88 23.95 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.386 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 408' ' ' PRO . 18.8 t -34.42 -60.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 37.8 t -86.28 -56.97 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 25.1 p -140.18 128.94 23.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.3 p -114.4 147.25 39.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 71.72 -87.53 0.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -45.49 161.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 90.9 p -125.52 149.28 48.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -110.47 109.01 2.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -47.55 166.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -130.81 -51.89 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 138.2 -174.63 21.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -50.66 146.68 8.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -126.35 143.5 51.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -65.01 108.45 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.438 ' CG2' ' C ' ' A' ' 381' ' ' ASN . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.438 ' C ' ' CG2' ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 394' ' ' MET . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.11 2.94 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -86.05 -56.58 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 402' ' ' VAL . 7.3 mtp -61.53 -50.35 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 401' ' ' MET . 85.0 t -34.02 -47.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.64 148.47 25.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -104.68 130.71 52.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -66.57 120.12 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 28.9 t -48.66 154.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -144.58 -162.03 9.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 156.81 92.56 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.7 -1.792 . . . . 0.0 112.31 0.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 79.7 p -81.19 121.83 26.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 54.7 m -79.53 -62.52 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 93.0 p -84.23 126.48 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -68.88 -59.96 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 164.78 88.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.6 m -131.82 117.58 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.5 m -83.71 41.93 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 64.74 57.97 11.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.53 91.8 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 86.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 76.15 161.59 11.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -103.81 86.46 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.04 160.49 35.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? -111.3 118.3 35.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.404 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . 0.457 ' CG2' ' HB1' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.457 ' HB1' ' CG2' ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.459 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.47 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.95 7.66 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -74.56 -59.88 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 48.3 tpp -63.95 -51.13 65.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 394' ' ' MET . 88.5 t -40.92 106.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.174 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.2 152.44 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -58.77 160.09 6.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -95.27 86.79 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . 0.421 ' C ' ' HA ' ' A' ' 408' ' ' PRO . 1.7 t -131.6 80.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 124.08 -70.82 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.424 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.8 Cg_endo -69.75 -14.86 12.5 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.365 0.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 92.1 p -76.98 108.83 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 5.6 m -105.44 165.65 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.453 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 364' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 363' ' ' GLY . 58.6 m -35.72 147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 110.879 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 79.1 p -55.48 168.59 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 166.87 -61.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -98.12 -45.79 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.383 . . . . 0.0 110.847 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 42.1 t -64.47 143.2 58.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 151.83 109.61 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -97.47 122.56 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.9 96.09 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 157.01 130.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -56.04 132.53 50.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 151.07 6.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.897 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 22.1 mmtt -110.26 108.85 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 377' ' ' CYS . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 388' ' ' GLU . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 0.62 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.15 -46.91 8.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 6.6 tpt -82.91 43.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 80.6 t -121.86 120.82 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.78 -31.41 40.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -68.43 125.14 25.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.62 84.46 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 95.07 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.431 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 172.64 -71.24 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.431 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.76 131.34 18.98 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 -1.814 . . . . 0.0 112.332 0.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.8 p -101.42 -59.45 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.5 t -61.33 147.78 43.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 16.9 t -39.05 -59.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.1 t -83.92 133.96 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 148.44 101.71 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 75.1 p -106.61 82.67 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 18.3 t -127.74 97.02 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -156.34 -117.0 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.512 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -87.33 146.73 25.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.971 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.15 -50.83 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.07 154.24 8.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -92.79 64.36 2.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.48 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -126.17 139.62 53.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt -53.5 112.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.432 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -17.57 37.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.32 -39.67 53.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 89.1 mmm -97.03 50.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.04 119.39 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.7 129.59 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.91 88.51 5.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -122.4 -49.86 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.9 m -138.18 153.99 49.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.441 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -62.09 -71.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.441 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 54.0 Cg_endo -69.77 179.96 20.86 Favored 'Cis proline' 0 C--O 1.231 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.398 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 54.5 p -63.92 172.69 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 27.1 t -45.2 -52.36 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 9.1 t -127.93 163.01 25.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.9 m -126.13 95.5 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 93.93 122.57 3.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.3 m -60.05 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.0 m -151.35 172.02 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -132.72 61.31 0.66 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -122.71 -46.6 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.336 . . . . 0.0 110.859 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -87.61 153.08 21.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 113.26 -158.24 14.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 77.51 -92.64 1.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -158.89 141.51 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.472 ' N ' ' HE3' ' A' ' 375' ' ' LYS . 0.4 OUTLIER -78.17 123.21 26.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.48 ' O ' ' N ' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.457 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -46.78 11.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 47.65 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 75.1 t -133.87 -52.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.33 113.76 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -112.13 103.12 11.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.03 142.94 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 27.5 p -78.13 101.42 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.21 -158.43 7.96 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 139.94 57.47 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.338 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -101.89 158.97 15.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.2 m -120.83 100.12 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.4 t -95.27 -52.25 4.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.6 t -64.3 145.35 56.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.93 31.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.492 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 p -159.08 173.56 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 89.7 p -102.05 99.08 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 45.57 -145.93 2.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -117.87 42.79 2.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.96 87.18 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.58 -134.11 15.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.49 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 109.13 -168.57 13.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -62.13 133.55 55.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -55.79 123.44 14.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 380' ' ' CYS . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 388' ' ' GLU . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 387' ' ' THR . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 388' ' ' GLU . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.5 Cg_endo -69.79 0.96 4.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -70.85 -40.32 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.06 76.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 58.1 t -114.97 93.96 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -42.53 104.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.9 164.0 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.59 137.54 58.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.3 t -89.58 -58.12 2.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 165.37 -162.04 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 108.46 0.78 Allowed 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 -1.809 . . . . 0.0 112.35 0.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 39.9 t -60.46 103.17 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 411' ' ' GLY . 23.0 m -137.55 170.92 15.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 410' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 43.7 p -116.01 -55.46 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.896 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 39.2 m -68.95 157.48 36.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 152.55 98.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.469 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 t -147.38 152.72 38.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 110.846 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 52.3 p -101.46 170.8 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.48 -66.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -88.62 131.12 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -54.72 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -154.77 -155.12 7.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 122.19 -90.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -119.95 175.8 5.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.42 ' C ' HG13 ' A' ' 376' ' ' ILE . 13.4 mmtp -122.33 119.94 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 377' ' ' CYS . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.466 HG21 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 394' ' ' MET . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.466 ' CD ' HG21 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 0.44 5.69 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.74 -34.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 10.9 ptp -118.35 70.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.0 t -147.93 108.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -130.2 83.14 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -152.51 139.86 19.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -74.92 89.08 2.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.424 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -101.15 170.64 21.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.424 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.73 134.23 28.63 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.3 t -75.21 96.39 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -142.52 143.51 32.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 m -86.48 82.95 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.8 t -111.8 81.83 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 367' ' ' SER . . . -175.17 -41.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 366' ' ' GLY . 3.1 m -37.76 -48.3 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.5 p -88.63 105.45 17.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 167.63 -61.21 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.41 133.34 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.44 83.4 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 177.73 -92.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 97.05 54.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.404 ' CD ' HD11 ' A' ' 376' ' ' ILE . 14.0 ptp180 -116.76 165.3 13.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -120.3 107.64 13.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 377' ' ' CYS . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.471 ' N ' HG21 ' A' ' 376' ' ' ILE . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 384' ' ' PHE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 388' ' ' GLU . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.475 ' N ' HG21 ' A' ' 387' ' ' THR . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 384' ' ' PHE . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -50.37 -51.73 43.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.432 ' O ' ' C ' ' A' ' 402' ' ' VAL . 4.7 mtt -47.84 -49.82 28.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 401' ' ' MET . 96.1 t -34.78 118.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -48.09 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -43.6 125.31 3.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -58.06 159.37 5.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 87.8 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.443 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -67.43 168.75 38.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.443 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.6 Cg_endo -69.77 174.14 41.79 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.327 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 90.7 p -96.46 125.95 41.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.1 m -92.57 42.06 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 1.9 m -87.0 95.41 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 367' ' ' SER . 58.8 m -128.3 42.45 3.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 365' ' ' SER . . . -37.42 92.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 365' ' ' SER . 64.1 m -141.23 152.04 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 19.6 m -79.18 146.77 32.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -128.89 -89.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.92 -61.58 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -98.1 -50.75 4.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.04 170.79 43.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -53.6 101.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -106.76 121.11 43.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt -86.92 126.16 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.504 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -30.4 22.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -40.82 -55.4 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.9 ttt -75.86 -54.41 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.22 108.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.52 152.55 45.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -113.61 161.65 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -118.45 98.58 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 64.7 p -42.99 -50.04 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -68.98 168.57 44.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.518 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.5 Cg_endo -69.81 125.12 8.23 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.332 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.41 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 54.2 p -127.44 173.38 9.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.2 t -159.18 148.64 18.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.0 m -155.57 153.92 30.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.5 m -125.16 152.77 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -149.75 -162.62 10.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.1 t -81.57 80.13 8.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.865 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.8 t -85.09 -53.32 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 67.66 163.59 2.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -107.95 83.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.63 155.41 19.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 62.67 157.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 149.13 -98.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.89 141.96 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 120.95 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.4 ' CG ' ' SD ' ' A' ' 401' ' ' MET . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 388' ' ' GLU . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.439 ' N ' HG21 ' A' ' 387' ' ' THR . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.568 HD21 ' CD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 1.82 4.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.32 -56.46 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 378' ' ' PRO . 64.2 mtp -79.67 44.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.3 t -134.52 82.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -126.42 -42.19 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -112.51 130.54 55.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -73.39 121.38 20.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.4 m -55.85 -58.82 6.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.845 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 41.39 -160.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.59 93.14 Favored 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.359 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 40.3 p -108.86 143.63 37.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.2 m -61.35 -44.49 97.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 61.1 m -54.88 119.61 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.2 m -123.94 90.2 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 171.87 158.75 16.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.0 m -114.58 42.24 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.827 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -53.93 165.98 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -76.58 -58.54 3.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.91 162.99 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -122.15 168.29 12.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.6 83.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -134.83 45.36 1.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -101.2 121.44 41.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.486 ' CG2' ' C ' ' A' ' 381' ' ' ASN . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 381' ' ' ASN . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.486 ' C ' ' CG2' ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 394' ' ' MET . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -17.17 37.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -49.72 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 17.7 ttm -71.03 -50.7 31.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 403' ' ' GLU . 84.3 t -38.83 -45.88 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.196 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 402' ' ' VAL . 0.5 OUTLIER -36.77 114.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -129.76 85.99 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -119.63 121.86 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 57.8 m -112.8 97.42 6.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.457 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -42.59 -73.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.457 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.3 Cg_endo -69.84 133.78 27.1 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.3 0.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 78.0 p -69.34 85.85 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -105.64 41.92 1.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 7.5 t -59.46 -55.51 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.5 p -70.99 161.32 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.823 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 146.15 90.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.9 m -89.2 96.07 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 22.0 m -150.66 151.18 32.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -171.8 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -133.87 101.45 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.6 -61.01 2.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 120.34 173.3 14.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 74.86 -58.44 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -116.39 114.36 24.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt -63.52 127.7 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 377' ' ' CYS . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.455 ' N ' HG23 ' A' ' 376' ' ' ILE . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 380' ' ' CYS . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 389' ' ' ALA . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.406 ' HB2' ' CD1' ' A' ' 384' ' ' PHE . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.43 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -6.64 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -75.31 -59.58 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 2.5 tpt -59.16 -56.97 15.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 394' ' ' MET . 96.9 t -45.99 115.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -126.83 93.02 3.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -57.1 154.41 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -107.33 109.07 20.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 m -62.61 -53.76 49.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.42 -167.98 26.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.512 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -35.99 2.5 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.346 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.3 p -76.65 122.42 24.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.9 t -148.54 136.86 21.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.6 m -115.91 153.82 30.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.375 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 64.5 m -132.5 162.44 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 68.64 77.42 0.38 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.488 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 109.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -68.77 110.43 4.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 56.61 -176.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -112.7 155.82 23.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.54 93.0 3.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -139.02 43.17 1.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 126.49 48.18 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -129.7 143.48 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? -109.48 122.36 47.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 384' ' ' PHE . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.448 ' CD2' HD23 ' A' ' 390' ' ' LEU . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -1.38 8.33 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -74.49 -57.41 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 33.2 ttm -76.27 -48.57 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.37 125.98 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -128.78 159.68 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -85.54 -68.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 406' ' ' SER . 1.3 pm0 -52.59 156.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 405' ' ' GLN . 3.7 m -34.52 -45.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 409' ' ' SER . . . -48.67 172.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.403 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.72 119.56 4.11 Favored 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.336 -0.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.453 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 97.8 p -74.52 143.4 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.0 t -131.77 130.06 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 89.3 p -148.71 155.05 40.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.2 m -38.6 -44.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 108.44 100.51 2.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.2 t -158.79 128.21 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.844 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 15.6 t -47.05 109.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -152.45 164.61 30.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -82.29 113.56 20.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -92.2 106.59 18.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -85.12 78.98 1.94 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -55.26 164.13 4.07 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -60.32 96.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 50.6 mmtt -61.48 108.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 381' ' ' ASN . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.464 ' C ' ' O ' ' A' ' 380' ' ' CYS . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -27.38 26.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.07 -66.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 86.2 mtp -54.98 -55.86 26.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 92.1 t -39.08 121.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -101.17 139.18 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -159.21 141.46 13.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -126.34 108.94 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.4 t -85.64 133.09 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -142.42 -178.47 18.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -34.74 2.95 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.645 -1.815 . . . . 0.0 112.369 0.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.2 p -89.65 123.53 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 4.4 t -75.63 153.64 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 63.2 p -130.26 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.9 t -156.67 125.54 5.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 169.6 -147.76 11.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 87.6 p -131.61 174.52 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 57.9 m -152.97 156.3 38.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 38.01 82.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -84.67 86.73 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -129.29 167.98 16.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 66.67 155.72 0.4 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -149.18 162.67 29.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 159.23 28.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp -99.33 126.67 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.34 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 401' ' ' MET . 13.8 pt-20 -43.89 -42.08 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.424 ' N ' ' HG3' ' A' ' 400' ' ' GLU . 8.5 tpt -89.44 48.7 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.408 HG21 ' C ' ' A' ' 401' ' ' MET . 97.8 t -141.62 139.82 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -50.51 101.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.467 ' CG ' ' N ' ' A' ' 405' ' ' GLN . 19.5 p90 -39.73 -47.12 2.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . 0.467 ' N ' ' CG ' ' A' ' 404' ' ' TYR . 37.5 tt0 -51.29 135.04 27.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -114.01 -49.58 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.43 -159.01 2.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.513 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -14.67 12.45 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.354 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 t -68.12 120.27 14.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 57.5 m -153.2 133.1 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 65.4 p -80.96 43.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.3 t -107.78 122.67 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 175.26 -126.76 1.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 29.2 t -118.23 91.83 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 81.1 p -126.03 97.06 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.812 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 105.07 51.87 0.86 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.21 -51.09 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.61 118.31 20.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.17 170.98 19.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.61 -142.74 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.501 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.42 107.35 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 32.6 mmtt -64.16 116.87 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.455 ' O ' ' C ' ' A' ' 377' ' ' CYS . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 391' ' ' ARG . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 400' ' ' GLU . 54.0 Cg_endo -69.77 -30.72 21.79 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 399' ' ' PRO . 4.3 tp10 -35.76 -65.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 402' ' ' VAL . 10.2 mtm -54.53 -56.9 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 401' ' ' MET . 84.7 t -37.06 127.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.97 83.75 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -74.44 130.29 39.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.81 170.23 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 96.0 p -153.14 155.7 37.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.65 -161.2 24.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.75 1.47 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.32 0.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 2.7 t -66.3 154.25 40.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 32.6 p -88.2 114.7 25.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 96.6 p -68.41 87.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.7 t -94.93 143.23 26.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.65 48.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 28.7 t -129.54 113.96 15.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.2 t -107.16 102.95 12.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 130.87 -76.96 0.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -122.91 120.22 32.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -146.32 137.19 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.2 -116.63 4.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -136.93 124.96 3.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -65.89 107.49 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp -70.81 125.52 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.443 ' N ' HG22 ' A' ' 376' ' ' ILE . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.534 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.534 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 394' ' ' MET . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -4.73 14.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -60.88 -60.71 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -72.72 -46.79 51.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 98.3 t -41.22 124.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 104.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.0 135.27 18.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -122.44 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 79.5 p -113.56 164.09 14.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 64.89 171.91 2.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.421 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.8 -14.01 12.52 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.352 0.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 67.8 m -80.52 -71.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 13.9 m -60.75 143.63 54.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 17.7 t -133.36 162.85 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 41.0 t -108.32 150.34 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.73 70.27 0.28 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 31.4 m -104.73 143.09 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.888 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 53.7 p -59.38 -52.13 66.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.95 146.92 17.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -120.07 -49.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.38 103.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -136.75 -114.7 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -161.11 116.24 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.53 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.27 173.15 9.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.426 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? -62.6 110.72 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.426 HG13 ' C ' ' A' ' 375' ' ' LYS . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 380' ' ' CYS . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . 0.555 ' CD1' ' HB3' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.555 ' HB3' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -20.16 35.19 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -58.36 -57.02 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.813 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 83.5 mmm -67.24 -56.55 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.9 t -47.37 -48.41 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -128.99 106.47 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 405' ' ' GLN . 27.5 t80 -47.12 -56.39 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLN . . . . . 0.561 ' HG3' ' CD2' ' A' ' 404' ' ' TYR . 57.5 mt-30 -125.73 83.16 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 67.6 p -87.91 -48.13 8.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.431 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 66.14 170.89 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' PRO . . . . . 0.431 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.8 Cg_endo -69.81 176.96 30.66 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.336 0.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.6 m -91.89 -60.73 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 50.7 m -156.32 170.14 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.731 0.3 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.647 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 389' ' ' ALA . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 394' ' ' MET . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.334 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.731 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 394' ' ' MET . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.485 HG23 ' H ' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.485 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.516 ' HB3' HD11 ' A' ' 390' ' ' LEU . 22.1 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.704 0.288 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 381' ' ' ASN . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HA ' HG22 ' A' ' 376' ' ' ILE . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 389' ' ' ALA . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.512 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.441 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.763 0.316 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.764 ' HB3' HD11 ' A' ' 390' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.71 0.29 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.602 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 389' ' ' ALA . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 388' ' ' GLU . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 387' ' ' THR . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 375' ' ' LYS . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.679 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.462 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' A' ' 390' ' ' LEU . 13.4 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 381' ' ' ASN . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' A' ' 376' ' ' ILE . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.515 HG22 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 375' ' ' LYS . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.515 ' CD ' HG22 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 382' ' ' ALA . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 382' ' ' ALA . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 376' ' ' ILE . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.756 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 381' ' ' ASN . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.501 ' HD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 389' ' ' ALA . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.487 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 382' ' ' ALA . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.879 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 389' ' ' ALA . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 394' ' ' MET . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 382' ' ' ALA . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.481 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.723 0.297 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 381' ' ' ASN . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HA ' HG22 ' A' ' 376' ' ' ILE . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.739 ' HB3' HD13 ' A' ' 390' ' ' LEU . 50.6 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.753 0.311 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 381' ' ' ASN . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.716 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.564 ' HB3' HD11 ' A' ' 390' ' ' LEU . 32.6 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.746 0.307 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 381' ' ' ASN . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 376' ' ' ILE . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.488 ' C ' HG23 ' A' ' 376' ' ' ILE . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.584 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.584 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 375' ' ' LYS . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.643 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 389' ' ' ALA . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.643 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 394' ' ' MET . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.444 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.327 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 381' ' ' ASN . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.607 ' HA ' HG22 ' A' ' 376' ' ' ILE . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' PHE . . . . . 0.661 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.661 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 387' ' ' THR . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 19.9 m -112.9 -59.15 2.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.9 t -56.15 131.79 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 122.52 -92.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.7 m -51.61 105.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.884 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 91.5 p -62.66 88.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 89.0 101.11 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -55.31 139.6 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.89 137.13 32.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -79.0 154.72 39.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 374' ' ' ARG . . . 55.07 52.86 44.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 373' ' ' GLY . 19.0 tpt180 -36.66 102.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.863 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp -98.37 111.94 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 394' ' ' MET . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.647 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 389' ' ' ALA . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 402' ' ' VAL . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -0.19 6.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -66.34 -65.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.401 ' SD ' ' CE ' ' A' ' 394' ' ' MET . 9.2 ttp -55.55 -58.13 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.757 HG11 ' SG ' ' A' ' 395' ' ' CYS . 96.3 t -38.96 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -138.36 125.57 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -157.17 144.04 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -71.94 109.02 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.959 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 74.5 p -110.12 -52.71 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 115.03 175.36 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.16 41.84 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.376 0.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 94.2 p -99.67 175.21 5.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 92.1 p -71.79 137.01 47.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 3.1 t -48.57 147.64 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -86.87 92.76 9.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -153.43 -177.18 26.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -66.77 -59.44 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 94.7 p -104.96 172.33 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 134.5 121.04 2.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -113.61 115.36 27.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.12 122.38 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -73.48 99.59 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -142.09 -51.99 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 375' ' ' LYS . 4.8 ptp85 -150.69 175.77 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -130.48 113.87 14.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.6 Cg_endo -69.7 -18.99 37.0 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.79 -44.34 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 32.8 mmm -89.63 46.08 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 54.8 t -122.56 140.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.9 -51.05 71.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -99.31 124.08 44.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.84 39.75 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -52.05 149.63 5.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -83.35 170.05 48.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 409' ' ' SER . 53.2 Cg_endo -69.78 178.88 23.95 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.386 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 408' ' ' PRO . 18.8 t -34.42 -60.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 37.8 t -86.28 -56.97 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 25.1 p -140.18 128.94 23.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.3 p -114.4 147.25 39.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 71.72 -87.53 0.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -45.49 161.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 90.9 p -125.52 149.28 48.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -110.47 109.01 2.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -47.55 166.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -130.81 -51.89 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 138.2 -174.63 21.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -50.66 146.68 8.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -126.35 143.5 51.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -65.01 108.45 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.731 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.448 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.11 2.94 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -86.05 -56.58 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 402' ' ' VAL . 7.3 mtp -61.53 -50.35 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 395' ' ' CYS . 85.0 t -34.02 -47.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.64 148.47 25.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -104.68 130.71 52.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -66.57 120.12 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 28.9 t -48.66 154.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -144.58 -162.03 9.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 156.81 92.56 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.7 -1.792 . . . . 0.0 112.31 0.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 79.7 p -81.19 121.83 26.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 54.7 m -79.53 -62.52 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 93.0 p -84.23 126.48 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -68.88 -59.96 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 164.78 88.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.6 m -131.82 117.58 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.5 m -83.71 41.93 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 64.74 57.97 11.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.53 91.8 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 86.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 76.15 161.59 11.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -103.81 86.46 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.04 160.49 35.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? -111.3 118.3 35.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.485 HG23 ' H ' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.485 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.492 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.648 ' N ' HG21 ' A' ' 402' ' ' VAL . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.95 7.66 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -74.56 -59.88 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 48.3 tpp -63.95 -51.13 65.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 395' ' ' CYS . 88.5 t -40.92 106.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.174 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.2 152.44 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -58.77 160.09 6.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -95.27 86.79 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.48 ' C ' ' HA ' ' A' ' 408' ' ' PRO . 1.7 t -131.6 80.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.414 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 124.08 -70.82 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.48 ' HA ' ' C ' ' A' ' 406' ' ' SER . 53.8 Cg_endo -69.75 -14.86 12.5 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.365 0.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 92.1 p -76.98 108.83 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 5.6 m -105.44 165.65 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.453 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 364' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 363' ' ' GLY . 58.6 m -35.72 147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 110.879 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 79.1 p -55.48 168.59 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 166.87 -61.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -98.12 -45.79 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.383 . . . . 0.0 110.847 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 42.1 t -64.47 143.2 58.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 151.83 109.61 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -97.47 122.56 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.9 96.09 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 157.01 130.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -56.04 132.53 50.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 151.07 6.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.897 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.516 ' HB3' HD11 ' A' ' 390' ' ' LEU . 22.1 mmtt -110.26 108.85 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 381' ' ' ASN . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HA ' HG22 ' A' ' 376' ' ' ILE . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 389' ' ' ALA . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.512 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.469 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 0.62 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.15 -46.91 8.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 6.6 tpt -82.91 43.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 395' ' ' CYS . 80.6 t -121.86 120.82 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 403' ' ' GLU . 0.5 OUTLIER -79.78 -31.41 40.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -68.43 125.14 25.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.62 84.46 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 95.07 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 172.64 -71.24 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.76 131.34 18.98 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 -1.814 . . . . 0.0 112.332 0.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.8 p -101.42 -59.45 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.5 t -61.33 147.78 43.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 16.9 t -39.05 -59.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.1 t -83.92 133.96 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 148.44 101.71 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 75.1 p -106.61 82.67 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 18.3 t -127.74 97.02 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -156.34 -117.0 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.512 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -87.33 146.73 25.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.971 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.15 -50.83 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.07 154.24 8.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -92.79 64.36 2.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.48 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -126.17 139.62 53.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.441 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt -53.5 112.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.4 Cg_endo -69.79 -17.57 37.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.32 -39.67 53.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 89.1 mmm -97.03 50.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.437 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 95.9 t -107.04 119.39 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.7 129.59 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.91 88.51 5.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -122.4 -49.86 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.9 m -138.18 153.99 49.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -62.09 -71.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.43 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 54.0 Cg_endo -69.77 179.96 20.86 Favored 'Cis proline' 0 C--O 1.231 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.398 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 54.5 p -63.92 172.69 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 27.1 t -45.2 -52.36 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 9.1 t -127.93 163.01 25.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.9 m -126.13 95.5 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 93.93 122.57 3.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.3 m -60.05 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.0 m -151.35 172.02 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -132.72 61.31 0.66 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -122.71 -46.6 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.336 . . . . 0.0 110.859 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -87.61 153.08 21.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 113.26 -158.24 14.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 77.51 -92.64 1.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -158.89 141.51 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.764 ' HB3' HD11 ' A' ' 390' ' ' LEU . 0.4 OUTLIER -78.17 123.21 26.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.602 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 389' ' ' ALA . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 388' ' ' GLU . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 387' ' ' THR . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 375' ' ' LYS . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.405 ' HA ' HG21 ' A' ' 402' ' ' VAL . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -46.78 11.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 47.65 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 395' ' ' CYS . 75.1 t -133.87 -52.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.33 113.76 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -112.13 103.12 11.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.03 142.94 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 27.5 p -78.13 101.42 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.21 -158.43 7.96 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 139.94 57.47 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.338 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -101.89 158.97 15.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.2 m -120.83 100.12 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.4 t -95.27 -52.25 4.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.6 t -64.3 145.35 56.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.93 31.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.492 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 p -159.08 173.56 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 89.7 p -102.05 99.08 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 45.57 -145.93 2.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -117.87 42.79 2.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.96 87.18 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.58 -134.11 15.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.49 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 109.13 -168.57 13.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.474 ' HG3' HD11 ' A' ' 376' ' ' ILE . 14.1 ptp180 -62.13 133.55 55.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -55.79 123.44 14.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.679 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.462 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.5 Cg_endo -69.79 0.96 4.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -70.85 -40.32 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.06 76.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 58.1 t -114.97 93.96 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -42.53 104.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.9 164.0 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.59 137.54 58.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.3 t -89.58 -58.12 2.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 165.37 -162.04 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 108.46 0.78 Allowed 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 -1.809 . . . . 0.0 112.35 0.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 39.9 t -60.46 103.17 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 411' ' ' GLY . 23.0 m -137.55 170.92 15.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 410' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 43.7 p -116.01 -55.46 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.896 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 39.2 m -68.95 157.48 36.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 152.55 98.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.469 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 t -147.38 152.72 38.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 110.846 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 52.3 p -101.46 170.8 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.48 -66.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -88.62 131.12 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -54.72 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -154.77 -155.12 7.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 122.19 -90.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -119.95 175.8 5.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' A' ' 390' ' ' LEU . 13.4 mmtp -122.33 119.94 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 381' ' ' ASN . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' A' ' 376' ' ' ILE . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.515 HG22 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 375' ' ' LYS . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.515 ' CD ' HG22 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 0.44 5.69 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.74 -34.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 10.9 ptp -118.35 70.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.0 t -147.93 108.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -130.2 83.14 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -152.51 139.86 19.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -74.92 89.08 2.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -101.15 170.64 21.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.427 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.73 134.23 28.63 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.3 t -75.21 96.39 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -142.52 143.51 32.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 m -86.48 82.95 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.8 t -111.8 81.83 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 367' ' ' SER . . . -175.17 -41.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 366' ' ' GLY . 3.1 m -37.76 -48.3 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.5 p -88.63 105.45 17.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 167.63 -61.21 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.41 133.34 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.44 83.4 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 177.73 -92.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 97.05 54.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.76 165.3 13.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -120.3 107.64 13.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 382' ' ' ALA . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -50.37 -51.73 43.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.432 ' O ' ' C ' ' A' ' 402' ' ' VAL . 4.7 mtt -47.84 -49.82 28.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 401' ' ' MET . 96.1 t -34.78 118.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -48.09 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -43.6 125.31 3.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -58.06 159.37 5.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 87.8 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -67.43 168.75 38.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.6 Cg_endo -69.77 174.14 41.79 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.327 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 90.7 p -96.46 125.95 41.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.1 m -92.57 42.06 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 1.9 m -87.0 95.41 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 367' ' ' SER . 58.8 m -128.3 42.45 3.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 365' ' ' SER . . . -37.42 92.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 365' ' ' SER . 64.1 m -141.23 152.04 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 19.6 m -79.18 146.77 32.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -128.89 -89.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.92 -61.58 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -98.1 -50.75 4.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.04 170.79 43.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -53.6 101.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -106.76 121.11 43.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt -86.92 126.16 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 382' ' ' ALA . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 376' ' ' ILE . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -30.4 22.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -40.82 -55.4 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.9 ttt -75.86 -54.41 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.22 108.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.52 152.55 45.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -113.61 161.65 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -118.45 98.58 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 64.7 p -42.99 -50.04 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -68.98 168.57 44.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.518 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.456 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.5 Cg_endo -69.81 125.12 8.23 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.332 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.425 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 54.2 p -127.44 173.38 9.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.2 t -159.18 148.64 18.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.0 m -155.57 153.92 30.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.5 m -125.16 152.77 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -149.75 -162.62 10.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.1 t -81.57 80.13 8.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.865 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.8 t -85.09 -53.32 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 67.66 163.59 2.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -107.95 83.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.63 155.41 19.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 62.67 157.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 149.13 -98.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.89 141.96 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 120.95 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 381' ' ' ASN . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.4 ' CG ' ' SD ' ' A' ' 401' ' ' MET . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.501 ' HD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 389' ' ' ALA . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.487 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 1.82 4.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.32 -56.46 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 378' ' ' PRO . 64.2 mtp -79.67 44.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.3 t -134.52 82.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -126.42 -42.19 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -112.51 130.54 55.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -73.39 121.38 20.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.4 m -55.85 -58.82 6.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.845 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 41.39 -160.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.59 93.14 Favored 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.359 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 40.3 p -108.86 143.63 37.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.2 m -61.35 -44.49 97.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 61.1 m -54.88 119.61 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.2 m -123.94 90.2 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 171.87 158.75 16.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.0 m -114.58 42.24 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.827 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -53.93 165.98 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -76.58 -58.54 3.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.91 162.99 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -122.15 168.29 12.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.6 83.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -134.83 45.36 1.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -101.2 121.44 41.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 382' ' ' ALA . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.879 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 389' ' ' ALA . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 402' ' ' VAL . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -17.17 37.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -49.72 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 17.7 ttm -71.03 -50.7 31.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 398' ' ' CYS . 84.3 t -38.83 -45.88 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.196 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 402' ' ' VAL . 0.5 OUTLIER -36.77 114.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -129.76 85.99 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -119.63 121.86 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 57.8 m -112.8 97.42 6.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -42.59 -73.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.3 Cg_endo -69.84 133.78 27.1 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.3 0.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 78.0 p -69.34 85.85 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -105.64 41.92 1.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 7.5 t -59.46 -55.51 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.5 p -70.99 161.32 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.823 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 146.15 90.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.9 m -89.2 96.07 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 22.0 m -150.66 151.18 32.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -171.8 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -133.87 101.45 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.6 -61.01 2.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 120.34 173.3 14.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 74.86 -58.44 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -116.39 114.36 24.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt -63.52 127.7 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 382' ' ' ALA . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.452 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -6.64 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -75.31 -59.58 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 2.5 tpt -59.16 -56.97 15.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' MET . 96.9 t -45.99 115.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -126.83 93.02 3.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -57.1 154.41 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -107.33 109.07 20.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 m -62.61 -53.76 49.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.42 -167.98 26.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.512 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -35.99 2.5 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.346 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.3 p -76.65 122.42 24.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.9 t -148.54 136.86 21.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.6 m -115.91 153.82 30.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.375 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 64.5 m -132.5 162.44 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 68.64 77.42 0.38 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.488 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 109.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -68.77 110.43 4.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 56.61 -176.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -112.7 155.82 23.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.54 93.0 3.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -139.02 43.17 1.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 126.49 48.18 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -129.7 143.48 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.481 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? -109.48 122.36 47.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 381' ' ' ASN . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HA ' HG22 ' A' ' 376' ' ' ILE . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -1.38 8.33 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -74.49 -57.41 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 33.2 ttm -76.27 -48.57 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.37 125.98 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -128.78 159.68 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -85.54 -68.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 406' ' ' SER . 1.3 pm0 -52.59 156.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 405' ' ' GLN . 3.7 m -34.52 -45.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.47 ' HA2' ' N ' ' A' ' 409' ' ' SER . . . -48.67 172.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.411 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.72 119.56 4.11 Favored 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.336 -0.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.47 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 97.8 p -74.52 143.4 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.0 t -131.77 130.06 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 89.3 p -148.71 155.05 40.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.2 m -38.6 -44.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 108.44 100.51 2.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.2 t -158.79 128.21 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.844 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 15.6 t -47.05 109.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -152.45 164.61 30.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -82.29 113.56 20.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -92.2 106.59 18.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -85.12 78.98 1.94 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -55.26 164.13 4.07 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -60.32 96.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.739 ' HB3' HD13 ' A' ' 390' ' ' LEU . 50.6 mmtt -61.48 108.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 381' ' ' ASN . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.716 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' CYS . . . . . 0.728 ' O ' HG23 ' A' ' 402' ' ' VAL . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -27.38 26.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.07 -66.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 86.2 mtp -54.98 -55.86 26.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 398' ' ' CYS . 92.1 t -39.08 121.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -101.17 139.18 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -159.21 141.46 13.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -126.34 108.94 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.4 t -85.64 133.09 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -142.42 -178.47 18.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -34.74 2.95 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.645 -1.815 . . . . 0.0 112.369 0.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.2 p -89.65 123.53 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 4.4 t -75.63 153.64 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 63.2 p -130.26 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.9 t -156.67 125.54 5.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 169.6 -147.76 11.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 87.6 p -131.61 174.52 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 57.9 m -152.97 156.3 38.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 38.01 82.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -84.67 86.73 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -129.29 167.98 16.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 66.67 155.72 0.4 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -149.18 162.67 29.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 159.23 28.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp -99.33 126.67 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.441 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.34 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 401' ' ' MET . 13.8 pt-20 -43.89 -42.08 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.433 ' N ' ' HG3' ' A' ' 400' ' ' GLU . 8.5 tpt -89.44 48.7 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 395' ' ' CYS . 97.8 t -141.62 139.82 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -50.51 101.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.467 ' CG ' ' N ' ' A' ' 405' ' ' GLN . 19.5 p90 -39.73 -47.12 2.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLN . . . . . 0.467 ' N ' ' CG ' ' A' ' 404' ' ' TYR . 37.5 tt0 -51.29 135.04 27.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -114.01 -49.58 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.43 -159.01 2.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.513 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -14.67 12.45 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.354 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 t -68.12 120.27 14.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 57.5 m -153.2 133.1 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 65.4 p -80.96 43.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.3 t -107.78 122.67 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 175.26 -126.76 1.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 29.2 t -118.23 91.83 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 81.1 p -126.03 97.06 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.812 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 105.07 51.87 0.86 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.21 -51.09 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.61 118.31 20.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.17 170.98 19.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.61 -142.74 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.501 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.42 107.35 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.564 ' HB3' HD11 ' A' ' 390' ' ' LEU . 32.6 mmtt -64.16 116.87 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 381' ' ' ASN . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 376' ' ' ILE . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.488 ' C ' HG23 ' A' ' 376' ' ' ILE . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.584 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.584 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 375' ' ' LYS . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 400' ' ' GLU . 54.0 Cg_endo -69.77 -30.72 21.79 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 399' ' ' PRO . 4.3 tp10 -35.76 -65.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 402' ' ' VAL . 10.2 mtm -54.53 -56.9 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 401' ' ' MET . 84.7 t -37.06 127.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.97 83.75 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -74.44 130.29 39.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.81 170.23 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 96.0 p -153.14 155.7 37.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.65 -161.2 24.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.75 1.47 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.32 0.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 2.7 t -66.3 154.25 40.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 32.6 p -88.2 114.7 25.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 96.6 p -68.41 87.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.7 t -94.93 143.23 26.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.65 48.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 28.7 t -129.54 113.96 15.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.2 t -107.16 102.95 12.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 130.87 -76.96 0.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -122.91 120.22 32.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -146.32 137.19 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.2 -116.63 4.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -136.93 124.96 3.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -65.89 107.49 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp -70.81 125.52 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.643 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 389' ' ' ALA . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.643 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' CYS . . . . . 0.534 ' HA ' HG21 ' A' ' 402' ' ' VAL . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -4.73 14.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -60.88 -60.71 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -72.72 -46.79 51.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' A' ' 395' ' ' CYS . 98.3 t -41.22 124.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 104.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.0 135.27 18.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -122.44 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 79.5 p -113.56 164.09 14.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 64.89 171.91 2.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.43 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.8 -14.01 12.52 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.352 0.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 67.8 m -80.52 -71.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 13.9 m -60.75 143.63 54.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 17.7 t -133.36 162.85 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 41.0 t -108.32 150.34 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.73 70.27 0.28 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 31.4 m -104.73 143.09 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.888 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 53.7 p -59.38 -52.13 66.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.95 146.92 17.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -120.07 -49.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.38 103.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -136.75 -114.7 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -161.11 116.24 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.53 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.711 ' HD3' HD11 ' A' ' 376' ' ' ILE . 0.0 OUTLIER -127.27 173.15 9.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.444 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? -62.6 110.72 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.711 HD11 ' HD3' ' A' ' 374' ' ' ARG . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.607 ' HA ' HG22 ' A' ' 376' ' ' ILE . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' PHE . . . . . 0.661 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.661 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 387' ' ' THR . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -20.16 35.19 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -58.36 -57.02 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.813 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 83.5 mmm -67.24 -56.55 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.9 t -47.37 -48.41 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -128.99 106.47 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.579 ' CD2' ' HG3' ' A' ' 405' ' ' GLN . 27.5 t80 -47.12 -56.39 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLN . . . . . 0.579 ' HG3' ' CD2' ' A' ' 404' ' ' TYR . 57.5 mt-30 -125.73 83.16 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 67.6 p -87.91 -48.13 8.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 66.14 170.89 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' PRO . . . . . 0.439 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.8 Cg_endo -69.81 176.96 30.66 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.336 0.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.6 m -91.89 -60.73 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 50.7 m -156.32 170.14 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.731 0.3 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.647 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 389' ' ' ALA . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 394' ' ' MET . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.334 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.785 0.326 . . . . 0.0 110.88 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.731 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . 0.406 ' C ' ' O ' ' A' ' 394' ' ' MET . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.485 HG23 ' H ' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.485 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.516 ' HB3' HD11 ' A' ' 390' ' ' LEU . 22.1 mmtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.704 0.288 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 381' ' ' ASN . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HA ' HG22 ' A' ' 376' ' ' ILE . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 389' ' ' ALA . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.512 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.441 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.763 0.316 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.764 ' HB3' HD11 ' A' ' 390' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.71 0.29 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.602 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 389' ' ' ALA . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 388' ' ' GLU . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 387' ' ' THR . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 375' ' ' LYS . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.758 0.313 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.679 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.462 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' A' ' 390' ' ' LEU . 13.4 mmtp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 381' ' ' ASN . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' A' ' 376' ' ' ILE . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.515 HG22 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 375' ' ' LYS . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.515 ' CD ' HG22 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 382' ' ' ALA . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 382' ' ' ALA . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 376' ' ' ILE . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.756 0.313 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 381' ' ' ASN . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.501 ' HD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 389' ' ' ALA . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.487 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 382' ' ' ALA . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.879 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 389' ' ' ALA . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . 0.433 ' N ' ' O ' ' A' ' 394' ' ' MET . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 382' ' ' ALA . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.481 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.723 0.297 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 381' ' ' ASN . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HA ' HG22 ' A' ' 376' ' ' ILE . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.739 ' HB3' HD13 ' A' ' 390' ' ' LEU . 50.6 mmtt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.753 0.311 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 381' ' ' ASN . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.716 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.744 0.307 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.564 ' HB3' HD11 ' A' ' 390' ' ' LEU . 32.6 mmtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.746 0.307 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 381' ' ' ASN . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 376' ' ' ILE . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.488 ' C ' HG23 ' A' ' 376' ' ' ILE . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.584 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.584 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 375' ' ' LYS . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.768 0.318 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.643 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 389' ' ' ALA . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.643 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 394' ' ' MET . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.444 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.327 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 381' ' ' ASN . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.607 ' HA ' HG22 ' A' ' 376' ' ' ILE . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . 0.661 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.661 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 387' ' ' THR . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 19.9 m -112.9 -59.15 2.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.9 t -56.15 131.79 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 122.52 -92.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 69.7 m -51.61 105.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.884 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 91.5 p -62.66 88.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 89.0 101.11 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -55.31 139.6 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -85.89 137.13 32.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -79.0 154.72 39.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.526 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 374' ' ' ARG . . . 55.07 52.86 44.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 373' ' ' GLY . 19.0 tpt180 -36.66 102.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.863 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 16.3 mmtp -98.37 111.94 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 79.1 mt -134.3 138.85 49.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 394' ' ' MET . 47.2 t -66.31 120.85 73.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 3.13 2.94 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.665 2.244 . . . . 0.0 112.379 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -106.11 -75.1 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.5 p -81.8 -30.14 32.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.8 m120 69.96 54.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.647 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -93.45 179.81 5.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -112.93 123.77 51.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 390' ' ' LEU . 31.5 m-85 -130.84 153.94 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -109.17 -50.18 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.553 HG23 ' H ' ' A' ' 389' ' ' ALA . 28.8 m -91.58 149.36 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 3.7 t -71.34 -15.32 62.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.178 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -68.96 -55.67 10.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.553 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -47.92 -51.58 22.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.3 mt -59.03 -48.52 81.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -44.42 -56.99 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.68 -62.21 3.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.499 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 12.3 t60 -38.93 -46.28 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.798 0.333 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.408 ' O ' ' C ' ' A' ' 395' ' ' CYS . 29.0 mmm -66.06 -56.6 10.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.757 ' SG ' HG11 ' A' ' 402' ' ' VAL . 3.9 m -36.69 -43.07 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -87.81 -59.71 2.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.0 t -49.2 -63.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 52.4 t -129.22 86.07 57.75 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.722 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -0.19 6.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -66.34 -65.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.897 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.401 ' SD ' ' CE ' ' A' ' 394' ' ' MET . 9.2 ttp -55.55 -58.13 9.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.757 HG11 ' SG ' ' A' ' 395' ' ' CYS . 96.3 t -38.96 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.117 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -138.36 125.57 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -157.17 144.04 18.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -71.94 109.02 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.959 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 74.5 p -110.12 -52.71 2.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.838 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 115.03 175.36 18.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.483 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.16 41.84 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.376 0.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 94.2 p -99.67 175.21 5.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.853 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 92.1 p -71.79 137.01 47.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.522 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 3.1 t -48.57 147.64 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.3 m -86.87 92.76 9.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -153.43 -177.18 26.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 16.5 m -66.77 -59.44 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 94.7 p -104.96 172.33 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 134.5 121.04 2.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -113.61 115.36 27.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.12 122.38 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -73.48 99.59 1.01 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -142.09 -51.99 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.446 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 375' ' ' LYS . 4.8 ptp85 -150.69 175.77 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.455 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -130.48 113.87 14.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 78.4 mt -142.5 140.26 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 35.4 t -68.34 119.92 71.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.643 0.735 . . . . 0.0 110.907 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 2.8 3.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -106.42 -65.53 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 25.7 p -89.62 -30.0 18.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 68.64 52.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.919 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.679 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -97.48 161.21 13.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -96.84 126.75 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 15.3 m-85 -129.06 153.83 47.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -103.33 -52.52 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.8 145.73 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 388' ' ' GLU . 21.8 m -65.84 -50.51 64.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 387' ' ' THR . 60.5 mt-10 -36.78 -47.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.49 5.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 26.2 mt -51.2 -48.17 62.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -46.76 -61.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.01 -59.07 5.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -39.52 -50.54 2.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 84.3 mtp -67.45 -43.0 82.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.4 t -44.68 -43.53 8.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -91.44 -48.09 7.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.2 t -55.74 -65.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.2 81.03 67.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.6 Cg_endo -69.7 -18.99 37.0 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.669 2.246 . . . . 0.0 112.306 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.79 -44.34 97.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 32.8 mmm -89.63 46.08 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 54.8 t -122.56 140.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.9 -51.05 71.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -99.31 124.08 44.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -117.84 39.75 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.0 t -52.05 149.63 5.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -83.35 170.05 48.35 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 409' ' ' SER . 53.2 Cg_endo -69.78 178.88 23.95 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 -1.808 . . . . 0.0 112.386 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 408' ' ' PRO . 18.8 t -34.42 -60.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.879 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 37.8 t -86.28 -56.97 3.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.534 -0.227 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 25.1 p -140.18 128.94 23.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.3 p -114.4 147.25 39.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.858 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 71.72 -87.53 0.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 22.9 t -45.49 161.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 90.9 p -125.52 149.28 48.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -110.47 109.01 2.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -47.55 166.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.34 . . . . 0.0 110.919 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -130.81 -51.89 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 138.2 -174.63 21.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -50.66 146.68 8.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -126.35 143.5 51.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.892 0.377 . . . . 0.0 110.87 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 0.0 OUTLIER -65.01 108.45 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.0 mt -146.67 126.36 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 2.1 t -42.36 116.27 1.77 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.595 0.712 . . . . 0.0 110.913 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 3.7 2.62 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.703 2.269 . . . . 0.0 112.364 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -107.36 -51.39 2.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 24.2 p -119.99 24.11 10.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.3 p-10 40.97 25.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.731 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.11 136.11 15.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.095 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -99.52 130.59 45.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -145.61 170.65 16.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 -113.73 -48.8 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -96.62 160.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 388' ' ' GLU . 90.7 m -71.96 -49.46 37.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 387' ' ' THR . 29.2 tt0 -34.7 -53.23 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.82 -65.43 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 19.7 mt -49.76 -48.06 50.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -42.53 -59.84 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -69.7 -65.29 2.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 392' ' ' GLY . 35.7 t60 -36.27 -45.39 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.842 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 395' ' ' CYS . 61.9 mtp -64.36 -59.07 4.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.448 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.5 m -36.78 -44.46 0.48 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.62 -42.06 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.7 t -57.69 -65.75 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.3 t -130.07 81.82 67.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.677 0.751 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 3.11 2.94 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -86.05 -56.58 3.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.446 ' O ' ' C ' ' A' ' 402' ' ' VAL . 7.3 mtp -61.53 -50.35 73.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.448 HG21 ' HA ' ' A' ' 395' ' ' CYS . 85.0 t -34.02 -47.72 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.099 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -154.64 148.47 25.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -104.68 130.71 52.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -66.57 120.12 12.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 28.9 t -48.66 154.61 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -144.58 -162.03 9.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 156.81 92.56 Favored 'Cis proline' 0 C--O 1.231 0.143 0 C-N-CA 122.7 -1.792 . . . . 0.0 112.31 0.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 79.7 p -81.19 121.83 26.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 54.7 m -79.53 -62.52 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.495 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 93.0 p -84.23 126.48 33.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 2.2 t -68.88 -59.96 2.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 164.78 88.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 39.6 m -131.82 117.58 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 66.5 m -83.71 41.93 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 64.74 57.97 11.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.493 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -128.53 91.8 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 86.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 76.15 161.59 11.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -103.81 86.46 0.52 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.04 160.49 35.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.909 0.385 . . . . 0.0 110.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 3.4 mptp? -111.3 118.3 35.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 375' ' ' LYS . 94.3 mt -151.51 120.09 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.159 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 48.7 t -46.65 117.24 4.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 3.14 2.91 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.672 2.248 . . . . 0.0 112.378 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -104.97 -69.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 22.7 p -84.29 -26.81 28.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 55.0 t30 65.02 49.41 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -89.63 178.43 6.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -113.62 120.88 42.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.568 ' CZ ' ' CD2' ' A' ' 393' ' ' HIS . 97.3 m-85 -122.2 149.41 43.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.51 -44.53 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.485 HG23 ' H ' ' A' ' 389' ' ' ALA . 34.3 m -90.17 -175.28 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.3 t -106.11 -33.75 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 389' ' ' ALA . 18.5 pm0 -60.11 -36.74 78.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.485 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -57.95 -57.96 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.507 HD21 ' CD1' ' A' ' 384' ' ' PHE . 31.5 mt -53.75 -47.34 70.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -47.09 -59.59 3.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.28 -57.55 6.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.568 ' CD2' ' CZ ' ' A' ' 384' ' ' PHE . 14.3 t60 -42.38 -47.52 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.0 110.848 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.492 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 8.4 mmm -64.49 -52.57 57.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.648 ' N ' HG21 ' A' ' 402' ' ' VAL . 4.0 t -39.78 -46.22 1.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -84.62 -58.04 2.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.944 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 11.3 t -49.96 -68.17 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 7.9 t -121.64 83.65 42.09 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.732 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.95 7.66 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -74.56 -59.88 2.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 48.3 tpp -63.95 -51.13 65.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 395' ' ' CYS . 88.5 t -40.92 106.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.174 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.2 152.44 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -58.77 160.09 6.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -95.27 86.79 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.48 ' C ' ' HA ' ' A' ' 408' ' ' PRO . 1.7 t -131.6 80.68 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.414 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 124.08 -70.82 0.45 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.481 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.48 ' HA ' ' C ' ' A' ' 406' ' ' SER . 53.8 Cg_endo -69.75 -14.86 12.5 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 -1.786 . . . . 0.0 112.365 0.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 92.1 p -76.98 108.83 10.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 5.6 m -105.44 165.65 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.453 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 364' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 363' ' ' GLY . 58.6 m -35.72 147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 110.879 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 79.1 p -55.48 168.59 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 166.87 -61.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 9.6 m -98.12 -45.79 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.383 . . . . 0.0 110.847 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 42.1 t -64.47 143.2 58.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 151.83 109.61 0.43 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -97.47 122.56 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.9 96.09 2.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 157.01 130.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -56.04 132.53 50.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 151.07 6.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.897 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.516 ' HB3' HD11 ' A' ' 390' ' ' LEU . 22.1 mmtt -110.26 108.85 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 381' ' ' ASN . 98.4 mt -139.16 123.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.2 t -49.09 112.9 2.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 4.07 2.39 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -104.39 -50.25 3.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.9 p -126.72 24.48 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.436 ' HA ' HG22 ' A' ' 376' ' ' ILE . 65.4 m-80 37.7 28.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -55.12 134.62 49.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.082 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -91.72 126.62 36.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -135.1 173.18 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -119.96 -42.67 2.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 389' ' ' ALA . 35.9 m -102.83 156.92 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 390' ' ' LEU . 35.9 m -68.85 -53.41 21.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 10.5 pt-20 -41.04 -43.77 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.902 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.512 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.97 -38.66 70.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 375' ' ' LYS . 19.9 mt -73.95 -45.67 48.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 388' ' ' GLU . 7.3 ttm105 -47.58 -53.73 13.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.59 -58.2 5.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -43.52 -50.27 7.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.792 0.329 . . . . 0.0 110.805 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 94.8 mtp -63.86 -50.83 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.469 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.3 m -40.86 -42.93 1.93 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.35 -55.88 3.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.8 -69.12 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 29.4 p -114.86 80.79 6.87 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.605 0.717 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 0.62 5.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.679 2.253 . . . . 0.0 112.338 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.15 -46.91 8.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 6.6 tpt -82.91 43.84 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 395' ' ' CYS . 80.6 t -121.86 120.82 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 403' ' ' GLU . 0.5 OUTLIER -79.78 -31.41 40.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -68.43 125.14 25.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.62 84.46 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.7 t -93.81 95.07 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.42 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . 172.64 -71.24 0.1 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.42 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.76 131.34 18.98 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.648 -1.814 . . . . 0.0 112.332 0.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.8 p -101.42 -59.45 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.5 t -61.33 147.78 43.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 16.9 t -39.05 -59.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.866 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 32.1 t -83.92 133.96 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 148.44 101.71 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 75.1 p -106.61 82.67 1.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 18.3 t -127.74 97.02 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -156.34 -117.0 0.54 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.512 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -87.33 146.73 25.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 0.0 110.971 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.15 -50.83 24.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.07 154.24 8.61 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.507 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -92.79 64.36 2.11 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.48 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -126.17 139.62 53.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.892 0.377 . . . . 0.0 110.844 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.441 ' HE3' ' CD1' ' A' ' 390' ' ' LEU . 19.0 mmmt -53.5 112.89 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 98.0 mt -149.48 137.87 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.86 121.99 80.31 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 110.87 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 3.73 2.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.701 2.268 . . . . 0.0 112.347 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -111.23 -67.92 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 27.3 p -86.78 -26.88 23.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 62.32 54.64 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -96.33 170.44 9.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -107.41 130.29 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -130.55 168.92 16.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -111.39 -60.99 1.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.3 m -89.94 176.99 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.11 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 388' ' ' GLU . 27.8 m -84.62 -53.87 5.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 387' ' ' THR . 0.0 OUTLIER -35.59 -40.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -55.24 -62.08 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.127 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 375' ' ' LYS . 20.3 mt -53.4 -42.53 67.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.921 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -48.57 -68.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -63.69 -53.98 34.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -43.42 -54.58 4.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 17.1 mmm -59.1 -45.08 91.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 35.6 t -45.56 -50.04 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.18 -57.92 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.46 -69.69 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.41 86.06 58.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.609 0.719 . . . . 0.0 110.837 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.437 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.4 Cg_endo -69.79 -17.57 37.37 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.735 2.29 . . . . 0.0 112.339 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.32 -39.67 53.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 89.1 mmm -97.03 50.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.437 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 95.9 t -107.04 119.39 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.081 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.7 129.59 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.91 88.51 5.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -122.4 -49.86 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.9 m -138.18 153.99 49.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -62.09 -71.49 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.518 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.43 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 54.0 Cg_endo -69.77 179.96 20.86 Favored 'Cis proline' 0 C--O 1.231 0.175 0 C-N-CA 122.652 -1.812 . . . . 0.0 112.398 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 54.5 p -63.92 172.69 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 27.1 t -45.2 -52.36 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 9.1 t -127.93 163.01 25.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.9 m -126.13 95.5 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.89 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 93.93 122.57 3.52 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 67.3 m -60.05 -50.65 72.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.0 m -151.35 172.02 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -132.72 61.31 0.66 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -122.71 -46.6 2.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.336 . . . . 0.0 110.859 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -87.61 153.08 21.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 113.26 -158.24 14.42 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.494 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 77.51 -92.64 1.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.519 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 374' ' ' ARG . 0.0 OUTLIER -158.89 141.51 14.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.857 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.764 ' HB3' HD11 ' A' ' 390' ' ' LEU . 0.4 OUTLIER -78.17 123.21 26.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 381' ' ' ASN . 59.4 mt -140.56 133.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.9 t -63.81 123.04 80.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.615 0.721 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 4.75 2.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.65 2.233 . . . . 0.0 112.34 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -110.61 -50.6 2.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 28.5 p -122.55 25.44 8.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 376' ' ' ILE . 34.9 m-20 38.44 27.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.591 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -48.31 139.8 8.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -102.68 106.14 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.602 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 39.4 m-85 -119.52 172.18 7.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.853 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -121.79 -43.67 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 389' ' ' ALA . 36.0 m -92.85 172.69 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 388' ' ' GLU . 9.4 t -86.66 -45.16 11.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 387' ' ' THR . 24.9 tt0 -46.82 -55.42 7.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.602 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -43.3 -52.36 5.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 375' ' ' LYS . 34.3 mt -60.98 -38.81 87.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -55.9 17.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -71.57 -55.12 7.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -47.44 -51.49 19.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 30.5 mmm -60.36 -49.03 79.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.405 ' HA ' HG21 ' A' ' 402' ' ' VAL . 1.8 m -43.43 -48.45 7.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -81.07 -59.21 2.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 30.7 t -49.82 -67.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.28 85.75 55.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.648 0.737 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -46.78 11.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 47.65 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.405 HG21 ' HA ' ' A' ' 395' ' ' CYS . 75.1 t -133.87 -52.13 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.33 113.76 4.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -112.13 103.12 11.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.96 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -119.03 142.94 47.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 27.5 p -78.13 101.42 7.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -148.21 -158.43 7.96 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 139.94 57.47 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.338 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.8 m -101.89 158.97 15.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.2 m -120.83 100.12 6.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.4 t -95.27 -52.25 4.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.6 t -64.3 145.35 56.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.93 31.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.492 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 23.7 p -159.08 173.56 16.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.836 0.351 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 89.7 p -102.05 99.08 9.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.84 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 45.57 -145.93 2.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.445 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -117.87 42.79 2.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.917 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.96 87.18 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 75.58 -134.11 15.84 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.49 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 109.13 -168.57 13.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.487 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.474 ' HG3' HD11 ' A' ' 376' ' ' ILE . 14.1 ptp180 -62.13 133.55 55.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.856 0.36 . . . . 0.0 110.892 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -55.79 123.44 14.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.92 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 382' ' ' ALA . 66.7 mt -149.8 124.5 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.47 115.79 1.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 0.0 110.896 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 5.07 1.85 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.658 2.239 . . . . 0.0 112.35 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -109.23 -53.46 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.7 p -118.12 25.46 10.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.679 ' HA ' HG22 ' A' ' 376' ' ' ILE . 3.6 m-80 34.13 33.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -53.71 147.08 12.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.062 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -100.65 113.35 26.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.462 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 44.2 m-85 -127.88 164.42 22.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 15.6 mmm-85 -116.96 -43.06 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 17.6 m -90.9 171.42 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.2 t -90.82 -38.73 12.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 389' ' ' ALA . 13.0 pt-20 -52.56 -47.66 66.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.462 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -52.83 -54.39 35.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.068 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 25.2 mt -57.91 -45.18 86.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -46.79 -57.54 4.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -73.04 -57.12 5.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -43.02 -51.56 5.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.31 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 57.4 mtp -64.41 -48.54 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 49.2 t -41.18 -43.13 2.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.51 -53.28 4.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 32.9 t -52.28 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 18.0 t -127.4 83.97 64.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.503 ' HA ' ' CG2' ' A' ' 402' ' ' VAL . 53.5 Cg_endo -69.79 0.96 4.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.381 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -70.85 -40.32 72.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 57.1 ttm -119.06 76.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 399' ' ' PRO . 58.1 t -114.97 93.96 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -42.53 104.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -70.9 164.0 26.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.59 137.54 58.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.3 t -89.58 -58.12 2.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 165.37 -162.04 35.41 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 108.46 0.78 Allowed 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.657 -1.809 . . . . 0.0 112.35 0.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 39.9 t -60.46 103.17 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 411' ' ' GLY . 23.0 m -137.55 170.92 15.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 410' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 43.7 p -116.01 -55.46 2.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.937 0.399 . . . . 0.0 110.896 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 39.2 m -68.95 157.48 36.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 152.55 98.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.469 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 13.3 t -147.38 152.72 38.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 110.846 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 52.3 p -101.46 170.8 7.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.48 -66.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -88.62 131.12 35.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -54.72 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -154.77 -155.12 7.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 122.19 -90.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.487 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -119.95 175.8 5.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.903 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' A' ' 390' ' ' LEU . 13.4 mmtp -122.33 119.94 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 381' ' ' ASN . 82.2 mt -151.41 111.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' O ' ' A' ' 376' ' ' ILE . 42.6 t -35.13 119.61 0.6 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.608 0.718 . . . . 0.0 110.894 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 5.84 1.55 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.739 2.292 . . . . 0.0 112.334 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -113.3 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.04 -22.38 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' A' ' 376' ' ' ILE . 30.7 m-20 59.45 55.0 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.746 ' HB3' ' CE1' ' A' ' 384' ' ' PHE . . . -95.59 179.83 5.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 130.79 55.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' A' ' 382' ' ' ALA . 32.5 m-85 -138.98 152.01 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -104.87 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.833 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.88 135.26 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.515 HG22 ' CD ' ' A' ' 391' ' ' ARG . 25.8 m -53.18 -49.9 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 387' ' ' THR . 10.7 pt-20 -35.26 -45.69 0.32 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -53.29 -56.86 13.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 375' ' ' LYS . 29.4 mt -50.89 -44.97 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.515 ' CD ' HG22 ' A' ' 387' ' ' THR . 0.1 OUTLIER -51.24 -63.03 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.36 -57.06 9.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -45.01 -41.02 7.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.836 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 390' ' ' LEU . 38.7 mmm -70.77 -44.88 65.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 19.8 t -48.76 -39.72 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -90.51 -52.39 4.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 8.3 t -51.52 -69.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 10.5 p -124.59 83.11 58.58 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.631 0.729 . . . . 0.0 110.859 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 0.44 5.69 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.628 2.219 . . . . 0.0 112.309 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -77.74 -34.26 52.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 10.9 ptp -118.35 70.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.0 t -147.93 108.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -130.2 83.14 2.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -152.51 139.86 19.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -74.92 89.08 2.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -101.15 170.64 21.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.479 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.427 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.73 134.23 28.63 Favored 'Cis proline' 0 C--N 1.341 0.172 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.364 -0.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.3 t -75.21 96.39 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -142.52 143.51 32.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 47.5 m -86.48 82.95 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.8 t -111.8 81.83 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 367' ' ' SER . . . -175.17 -41.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 366' ' ' GLY . 3.1 m -37.76 -48.3 1.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 31.5 p -88.63 105.45 17.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 167.63 -61.21 0.21 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -121.41 133.34 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.44 83.4 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 177.73 -92.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 97.05 54.58 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -116.76 165.3 13.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.903 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -120.3 107.64 13.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 382' ' ' ALA . 69.9 mt -130.69 139.73 50.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.103 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 26.0 t -58.7 116.39 15.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.638 0.733 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 2.25 3.73 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.653 2.236 . . . . 0.0 112.344 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 13.9 tpt85 -106.21 -67.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 31.2 p -84.53 -30.58 25.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 61.6 t30 70.07 47.62 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -93.19 162.97 13.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -92.05 136.86 32.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 382' ' ' ALA . 91.2 m-85 -142.13 148.0 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -105.86 -50.93 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 12.5 m -92.85 150.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.5 t -68.89 -32.67 72.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -53.85 -50.13 66.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.1 -56.85 5.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 27.5 mt -52.88 -50.79 63.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -43.05 -59.34 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 393' ' ' HIS . . . -72.59 -64.64 2.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 392' ' ' GLY . 10.0 t60 -37.76 -51.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 89.1 mtp -64.34 -44.87 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 5.7 t -43.6 -46.43 7.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -86.81 -50.45 6.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 9.3 t -53.11 -64.36 0.84 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 26.4 p -128.47 82.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.583 0.706 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -50.76 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -50.37 -51.73 43.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.432 ' O ' ' C ' ' A' ' 402' ' ' VAL . 4.7 mtt -47.84 -49.82 28.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.855 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 401' ' ' MET . 96.1 t -34.78 118.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -48.09 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -43.6 125.31 3.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 -58.06 159.37 5.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.7 t -104.05 87.8 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -67.43 168.75 38.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.452 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.6 Cg_endo -69.77 174.14 41.79 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.683 -1.799 . . . . 0.0 112.327 0.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 90.7 p -96.46 125.95 41.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 45.1 m -92.57 42.06 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.485 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 1.9 m -87.0 95.41 9.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.887 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 367' ' ' SER . 58.8 m -128.3 42.45 3.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 365' ' ' SER . . . -37.42 92.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 365' ' ' SER . 64.1 m -141.23 152.04 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 19.6 m -79.18 146.77 32.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -128.89 -89.45 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.462 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.92 -61.58 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -98.1 -50.75 4.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 81.04 170.79 43.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.494 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -53.6 101.57 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -106.76 121.11 43.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 23.2 mmmt -86.92 126.16 34.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.816 HG23 ' O ' ' A' ' 382' ' ' ALA . 68.8 mt -148.59 122.88 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 2.0 t -40.19 114.37 1.02 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.599 0.714 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 5.16 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.661 2.241 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -106.49 -53.9 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 31.8 p -114.21 15.19 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.482 ' HA ' HG22 ' A' ' 376' ' ' ILE . 18.1 m120 46.87 25.68 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -51.74 136.49 27.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.126 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -94.66 100.94 12.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.492 ' CE1' ' HB1' ' A' ' 389' ' ' ALA . 27.6 m-85 -111.33 163.22 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -119.18 -40.98 2.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.44 142.01 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 388' ' ' GLU . 33.3 m -59.86 -58.61 7.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 387' ' ' THR . 83.6 mt-10 -35.97 -53.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.492 ' HB1' ' CE1' ' A' ' 384' ' ' PHE . . . -47.79 -57.22 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.132 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 23.8 mt -51.73 -49.79 61.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -45.25 -58.3 3.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 395' ' ' CYS . . . -67.5 -67.89 1.83 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.434 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 392' ' ' GLY . 11.2 t60 -38.39 -39.2 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.836 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 86.5 mtp -72.28 -39.56 68.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.487 ' N ' ' O ' ' A' ' 392' ' ' GLY . 38.1 t -56.85 -44.98 82.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -82.81 -41.14 19.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 39.8 t -65.2 -62.96 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 30.7 t -127.88 81.9 69.43 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.648 0.737 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -30.4 22.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.645 2.23 . . . . 0.0 112.38 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -40.82 -55.4 2.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.9 ttt -75.86 -54.41 6.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 60.3 t -49.22 108.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.52 152.55 45.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -113.61 161.65 17.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -118.45 98.58 6.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 64.7 p -42.99 -50.04 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . -68.98 168.57 44.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.518 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.456 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.5 Cg_endo -69.81 125.12 8.23 Favored 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.332 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.425 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 54.2 p -127.44 173.38 9.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.2 t -159.18 148.64 18.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.0 m -155.57 153.92 30.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.921 0.391 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.5 m -125.16 152.77 44.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -149.75 -162.62 10.56 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 8.1 t -81.57 80.13 8.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 0.0 110.865 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 1.8 t -85.09 -53.32 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.874 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 67.66 163.59 2.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -107.95 83.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -89.63 155.41 19.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 62.67 157.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 149.13 -98.37 0.19 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.89 141.96 20.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.885 0.374 . . . . 0.0 110.888 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 120.95 21.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 381' ' ' ASN . 85.2 mt -135.36 127.1 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.133 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 52.7 t -54.65 120.52 28.01 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.729 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.4 ' CG ' ' SD ' ' A' ' 401' ' ' MET . 53.6 Cg_endo -69.82 2.72 3.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.344 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.46 -64.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.82 -28.64 15.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.4 m120 69.11 51.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.95 179.11 7.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -113.07 112.12 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.909 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.501 ' HD2' HD21 ' A' ' 390' ' ' LEU . 59.6 m-85 -122.76 170.06 10.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -120.92 -55.57 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.487 HG23 ' H ' ' A' ' 389' ' ' ALA . 33.2 m -90.26 164.25 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 8.5 t -75.95 -39.55 55.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.88 -57.9 5.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.487 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -44.09 -44.95 7.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.501 HD21 ' HD2' ' A' ' 384' ' ' PHE . 23.8 mt -68.01 -45.98 72.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -44.65 -59.72 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.03 -61.04 4.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -39.8 -53.89 2.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.771 0.32 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.14 -45.71 92.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 37.5 t -45.01 -45.17 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -86.08 -57.65 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.903 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 5.0 t -51.1 -60.4 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 39.1 t -128.89 83.5 66.0 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 1.82 4.08 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.725 2.283 . . . . 0.0 112.313 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.32 -56.46 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 378' ' ' PRO . 64.2 mtp -79.67 44.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 90.3 t -134.52 82.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -126.42 -42.19 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -112.51 130.54 55.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -73.39 121.38 20.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.4 m -55.85 -58.82 6.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.845 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 41.39 -160.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 155.59 93.14 Favored 'Cis proline' 0 C--O 1.231 0.157 0 C-N-CA 122.698 -1.793 . . . . 0.0 112.359 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 40.3 p -108.86 143.63 37.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.2 m -61.35 -44.49 97.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.47 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 61.1 m -54.88 119.61 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.2 m -123.94 90.2 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 171.87 158.75 16.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.482 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 54.0 m -114.58 42.24 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.827 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -53.93 165.98 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -76.58 -58.54 3.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -135.91 162.99 31.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -122.15 168.29 12.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 64.6 83.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -134.83 45.36 1.11 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -149.07 134.74 18.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.901 0.381 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -101.2 121.44 41.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 382' ' ' ALA . 47.4 mt -136.77 138.67 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 382' ' ' ALA . 4.2 t -56.37 118.64 22.9 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.605 0.717 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 4.38 2.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.307 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -108.72 -49.86 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.865 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.3 p -121.98 23.14 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.5 p-10 41.39 24.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.867 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.879 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -45.44 139.47 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.082 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -102.83 110.07 21.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -125.88 174.29 8.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -120.63 -42.99 2.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 389' ' ' ALA . 16.0 m -97.55 168.32 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 9.5 t -83.45 -35.22 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.69 -46.42 70.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -55.08 -52.29 63.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 31.0 mt -58.83 -43.5 90.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 31.2 tpt85 -49.75 -59.11 4.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.96 -56.73 7.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.465 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -43.77 -54.31 5.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 398' ' ' CYS . 90.9 mtp -61.26 -42.8 99.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 15.4 t -45.74 -47.77 15.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -85.1 -39.38 18.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.93 -65.83 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . 0.529 ' O ' HG23 ' A' ' 402' ' ' VAL . 44.8 t -125.88 81.23 66.17 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.62 0.724 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -17.17 37.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.672 2.248 . . . . 0.0 112.322 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -49.72 -64.93 0.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 17.7 ttm -71.03 -50.7 31.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 398' ' ' CYS . 84.3 t -38.83 -45.88 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.196 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 402' ' ' VAL . 0.5 OUTLIER -36.77 114.3 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -129.76 85.99 2.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -119.63 121.86 40.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 57.8 m -112.8 97.42 6.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 408' ' ' PRO . . . -42.59 -73.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.513 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.446 ' C ' ' HA3' ' A' ' 407' ' ' GLY . 53.3 Cg_endo -69.84 133.78 27.1 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.3 0.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 78.0 p -69.34 85.85 0.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.9 m -105.64 41.92 1.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 7.5 t -59.46 -55.51 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.5 p -70.99 161.32 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.823 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 146.15 90.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 2.9 m -89.2 96.07 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 22.0 m -150.66 151.18 32.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -171.8 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.487 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -133.87 101.45 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.917 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -55.6 -61.01 2.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 120.34 173.3 14.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 74.86 -58.44 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.519 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -116.39 114.36 24.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 29.8 mmtt -63.52 127.7 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 382' ' ' ALA . 77.1 mt -152.58 140.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.98 116.13 15.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.701 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 5.41 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -110.39 -53.08 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.481 ' O ' ' C ' ' A' ' 381' ' ' ASN . 22.2 p -118.7 25.96 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HA ' HG22 ' A' ' 376' ' ' ILE . 7.9 m120 31.65 51.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 376' ' ' ILE . . . -70.24 135.45 49.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -96.2 106.34 18.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -122.68 172.11 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 385' ' ' ARG . 3.0 mpt_? -120.12 -43.07 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.41 128.37 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 6.7 t -44.06 -40.6 4.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -41.45 -53.17 3.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -52.12 -54.73 26.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 25.1 mt -57.45 -43.03 83.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -48.76 -60.96 2.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.33 -57.53 6.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.498 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -44.26 -46.25 8.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.452 ' HB3' ' CG2' ' A' ' 402' ' ' VAL . 93.8 mtp -67.79 -41.48 83.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 2.7 t -48.63 -47.21 40.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -85.49 -45.52 11.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 13.0 t -62.81 -75.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 398' ' ' CYS . 30.0 p -110.69 79.03 1.67 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -6.64 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -75.31 -59.58 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 2.5 tpt -59.16 -56.97 15.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 394' ' ' MET . 96.9 t -45.99 115.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -126.83 93.02 3.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -57.1 154.41 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -107.33 109.07 20.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 4.0 m -62.61 -53.76 49.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.842 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -76.42 -167.98 26.44 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.512 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.79 -35.99 2.5 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.689 -1.796 . . . . 0.0 112.346 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.3 p -76.65 122.42 24.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.9 t -148.54 136.86 21.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 75.6 m -115.91 153.82 30.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.375 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 64.5 m -132.5 162.44 31.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 68.64 77.42 0.38 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.488 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 3.1 m -64.25 109.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.3 t -68.77 110.43 4.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 56.61 -176.39 1.05 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -112.7 155.82 23.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -121.54 93.0 3.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -139.02 43.17 1.19 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 126.49 48.18 0.19 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -129.7 143.48 50.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.481 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 2.6 mptm? -109.48 122.36 47.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.949 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 381' ' ' ASN . 81.9 mt -143.48 125.23 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.14 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 7.3 t -47.07 118.18 5.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.651 0.738 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 2.81 3.15 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.698 2.265 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -107.39 -68.82 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 29.0 p -86.58 -31.72 21.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.468 ' HA ' HG22 ' A' ' 376' ' ' ILE . 11.3 m-80 71.68 49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.83 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -115.53 126.5 54.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -137.58 158.27 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 36.0 ttt85 -98.35 -62.11 1.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -91.5 173.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 63.6 m -78.4 -48.73 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.2 -53.33 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -47.85 -45.12 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.481 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 32.9 mt -67.18 -41.04 86.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -50.41 -59.8 3.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.51 -59.17 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -45.07 -52.3 9.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 92.3 mtp -59.93 -39.86 86.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 4.6 t -50.31 -60.73 2.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.893 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -72.34 -38.53 68.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 35.6 t -59.32 -68.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 9.1 t -126.27 77.72 71.92 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -1.38 8.33 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -74.49 -57.41 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 33.2 ttm -76.27 -48.57 19.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.37 125.98 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -128.78 159.68 34.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -85.54 -68.19 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 406' ' ' SER . 1.3 pm0 -52.59 156.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 405' ' ' GLN . 3.7 m -34.52 -45.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.47 ' HA2' ' N ' ' A' ' 409' ' ' SER . . . -48.67 172.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.411 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.9 Cg_endo -69.72 119.56 4.11 Favored 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.707 -1.789 . . . . 0.0 112.336 -0.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.47 ' N ' ' HA2' ' A' ' 407' ' ' GLY . 97.8 p -74.52 143.4 44.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.0 t -131.77 130.06 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 89.3 p -148.71 155.05 40.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 0.0 110.84 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 15.2 m -38.6 -44.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.843 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 108.44 100.51 2.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 40.2 t -158.79 128.21 5.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 110.844 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 15.6 t -47.05 109.25 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -152.45 164.61 30.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.5 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -82.29 113.56 20.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -92.2 106.59 18.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -85.12 78.98 1.94 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -55.26 164.13 4.07 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -60.32 96.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.38 . . . . 0.0 110.877 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.739 ' HB3' HD13 ' A' ' 390' ' ' LEU . 50.6 mmtt -61.48 108.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 381' ' ' ASN . 89.9 mt -133.41 123.26 46.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.9 t -41.79 115.74 1.51 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.625 0.726 . . . . 0.0 110.917 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 5.49 1.67 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 0.0 112.358 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -109.77 -55.98 2.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 18.4 p -114.06 23.65 12.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.578 ' HA ' HG22 ' A' ' 376' ' ' ILE . 8.7 t30 32.52 37.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.716 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -63.18 139.53 58.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -93.23 138.92 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -149.33 163.96 36.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.6 ttt85 -112.06 -46.89 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.28 175.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 86.5 m -91.49 -51.85 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -41.05 -50.17 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -49.43 -57.95 6.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.739 HD13 ' HB3' ' A' ' 375' ' ' LYS . 20.5 mt -56.98 -42.11 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -47.81 -58.25 4.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.43 -57.34 7.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -45.39 -38.61 6.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 36.5 mmm -71.06 -45.84 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 3.6 m -52.16 -46.53 65.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.0 -51.94 8.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.917 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 46.8 t -53.81 -66.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . 0.728 ' O ' HG23 ' A' ' 402' ' ' VAL . 44.5 t -126.05 83.84 62.52 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.607 0.718 . . . . 0.0 110.924 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 -27.38 26.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.722 2.281 . . . . 0.0 112.328 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -57.07 -66.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 86.2 mtp -54.98 -55.86 26.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 398' ' ' CYS . 92.1 t -39.08 121.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.142 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -101.17 139.18 37.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -159.21 141.46 13.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -126.34 108.94 11.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 8.4 t -85.64 133.09 34.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.833 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -142.42 -178.47 18.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -34.74 2.95 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.645 -1.815 . . . . 0.0 112.369 0.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.2 p -89.65 123.53 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 4.4 t -75.63 153.64 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.475 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 63.2 p -130.26 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.348 . . . . 0.0 110.841 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.9 t -156.67 125.54 5.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.85 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 169.6 -147.76 11.28 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 87.6 p -131.61 174.52 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 57.9 m -152.97 156.3 38.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.855 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 38.01 82.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -84.67 86.73 7.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 110.949 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -129.29 167.98 16.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 66.67 155.72 0.4 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -149.18 162.67 29.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.77 159.23 28.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.373 . . . . 0.0 110.847 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 20.8 mmtp -99.33 126.67 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 80.8 mt -150.31 113.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 34.1 t -42.49 115.07 1.56 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.63 0.728 . . . . 0.0 110.873 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 4.47 2.17 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.686 2.257 . . . . 0.0 112.365 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -105.91 -65.1 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 28.8 p -88.76 -19.8 25.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 61.21 51.78 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -99.6 142.08 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.051 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -90.74 127.88 36.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.11 166.43 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -110.73 -46.92 3.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.92 162.88 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 388' ' ' GLU . 76.6 m -77.81 -54.01 6.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.155 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 387' ' ' THR . 11.2 pt-20 -34.85 -44.06 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -54.0 -60.34 3.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 29.1 mt -54.85 -45.06 74.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -45.39 -63.49 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -70.2 -58.49 6.06 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.516 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -40.32 -49.43 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 68.3 mtp -64.44 -48.38 75.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.441 ' HA ' HG21 ' A' ' 402' ' ' VAL . 2.6 t -43.49 -41.22 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -88.74 -61.55 1.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.19 -61.67 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.03 84.31 63.79 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.627 0.727 . . . . 0.0 110.915 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -46.34 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.752 2.302 . . . . 0.0 112.301 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 401' ' ' MET . 13.8 pt-20 -43.89 -42.08 5.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.433 ' N ' ' HG3' ' A' ' 400' ' ' GLU . 8.5 tpt -89.44 48.7 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' A' ' 395' ' ' CYS . 97.8 t -141.62 139.82 31.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -50.51 101.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.467 ' CG ' ' N ' ' A' ' 405' ' ' GLN . 19.5 p90 -39.73 -47.12 2.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . 0.467 ' N ' ' CG ' ' A' ' 404' ' ' TYR . 37.5 tt0 -51.29 135.04 27.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -114.01 -49.58 2.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.43 -159.01 2.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.513 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -14.67 12.45 Favored 'Cis proline' 0 C--N 1.341 0.177 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.354 0.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 t -68.12 120.27 14.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 57.5 m -153.2 133.1 13.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.862 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.49 -179.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 65.4 p -80.96 43.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.892 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 23.3 t -107.78 122.67 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.858 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 175.26 -126.76 1.2 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.548 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 29.2 t -118.23 91.83 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.882 0.372 . . . . 0.0 110.864 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 81.1 p -126.03 97.06 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.812 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 105.07 51.87 0.86 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -77.21 -51.09 11.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.333 . . . . 0.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.61 118.31 20.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 111.17 170.98 19.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . 154.61 -142.74 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.501 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.42 107.35 5.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 110.906 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.564 ' HB3' HD11 ' A' ' 390' ' ' LEU . 32.6 mmtt -64.16 116.87 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.507 HG22 ' HA ' ' A' ' 381' ' ' ASN . 86.1 mt -149.29 112.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.169 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 376' ' ' ILE . 49.0 t -34.19 116.55 0.5 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 5.42 1.69 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -100.19 -62.3 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . . . . . . . . . 24.7 p -100.85 -6.32 24.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.507 ' HA ' HG22 ' A' ' 376' ' ' ILE . 24.0 m-80 60.44 49.94 6.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.488 ' C ' HG23 ' A' ' 376' ' ' ILE . . . -98.51 134.42 41.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . 0.401 ' O ' ' CD ' ' A' ' 383' ' ' GLN . 0.0 OUTLIER -92.58 150.36 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.584 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 56.8 m-85 -146.85 176.41 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.415 ' NH1' ' HB3' ' A' ' 385' ' ' ARG . 19.6 ttp-105 -113.78 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.05 140.37 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 388' ' ' GLU . 80.5 m -48.9 -46.55 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 387' ' ' THR . 4.4 mp0 -36.42 -54.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.584 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -43.81 -59.88 2.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.099 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 375' ' ' LYS . 30.4 mt -58.76 -51.77 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 390' ' ' LEU . 30.9 ttt180 -35.86 -63.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.855 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 394' ' ' MET . . . -70.02 -67.84 1.8 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.451 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.462 ' C ' ' CD2' ' A' ' 393' ' ' HIS . 2.2 t60 -35.25 -32.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.478 ' N ' ' O ' ' A' ' 392' ' ' GLY . 48.3 mtp -76.08 -55.63 5.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 13.9 p -49.62 -21.96 1.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -99.64 -52.31 3.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 17.4 t -71.33 -65.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.06 82.23 65.31 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.844 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 400' ' ' GLU . 54.0 Cg_endo -69.77 -30.72 21.79 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.657 2.238 . . . . 0.0 112.346 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 399' ' ' PRO . 4.3 tp10 -35.76 -65.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . 0.406 ' O ' ' C ' ' A' ' 402' ' ' VAL . 10.2 mtm -54.53 -56.9 14.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 401' ' ' MET . 84.7 t -37.06 127.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.188 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -129.97 83.75 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -74.44 130.29 39.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -159.81 170.23 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 96.0 p -153.14 155.7 37.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.65 -161.2 24.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.75 1.47 Allowed 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.32 0.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 2.7 t -66.3 154.25 40.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 32.6 p -88.2 114.7 25.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 179.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 96.6 p -68.41 87.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.867 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.7 t -94.93 143.23 26.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -179.77 178.65 48.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 28.7 t -129.54 113.96 15.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.2 t -107.16 102.95 12.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . 130.87 -76.96 0.4 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.519 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -122.91 120.22 32.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 110.884 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -146.32 137.19 24.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.2 -116.63 4.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.451 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -136.93 124.96 3.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.495 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -65.89 107.49 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.894 0.378 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 390' ' ' LEU . 17.6 mttp -70.81 125.52 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.461 ' CG2' ' HA ' ' A' ' 381' ' ' ASN . 85.3 mt -148.46 145.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' A' ' 381' ' ' ASN . 5.0 t -71.11 117.78 59.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.591 0.71 . . . . 0.0 110.899 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 6.14 1.43 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.642 2.228 . . . . 0.0 112.352 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -108.75 -48.73 3.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 29.6 p -124.08 19.34 9.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 376' ' ' ILE . 8.7 m-20 42.47 32.21 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.487 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -49.04 134.55 17.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -101.77 96.44 7.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.643 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 68.4 m-85 -109.66 171.87 7.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -115.96 -47.72 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 389' ' ' ALA . 22.5 m -91.09 175.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 5.1 t -88.44 -23.94 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -64.8 -51.14 63.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.643 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -45.65 -54.1 8.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 375' ' ' LYS . 31.3 mt -59.16 -56.48 21.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 390' ' ' LEU . 3.0 tmm_? -35.33 -64.2 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -67.82 -53.81 21.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.46 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -43.4 -64.29 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 395' ' ' CYS . 87.7 mtp -52.91 -50.14 64.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . 0.534 ' HA ' HG21 ' A' ' 402' ' ' VAL . 5.5 t -37.3 -55.98 0.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -79.14 -54.05 6.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 12.6 t -45.99 -69.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.875 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 45.8 t -128.67 84.86 61.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -4.73 14.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.286 . . . . 0.0 112.31 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -60.88 -60.71 3.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -72.72 -46.79 51.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' A' ' 395' ' ' CYS . 98.3 t -41.22 124.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.08 104.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.0 135.27 18.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -122.44 130.25 52.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 79.5 p -113.56 164.09 14.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.43 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 64.89 171.91 2.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.43 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.7 Cg_endo -69.8 -14.01 12.52 Favored 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 -1.805 . . . . 0.0 112.352 0.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 67.8 m -80.52 -71.0 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 13.9 m -60.75 143.63 54.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.508 -179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 17.7 t -133.36 162.85 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.885 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 41.0 t -108.32 150.34 27.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.73 70.27 0.28 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' SER . . . . . . . . . . . . . 31.4 m -104.73 143.09 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.888 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 53.7 p -59.38 -52.13 66.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -143.95 146.92 17.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -120.07 -49.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 110.911 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.38 103.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . -136.75 -114.7 1.35 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.518 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -161.11 116.24 0.7 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.53 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.711 ' HD3' HD11 ' A' ' 376' ' ' ILE . 0.0 OUTLIER -127.27 173.15 9.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.444 ' C ' HG13 ' A' ' 376' ' ' ILE . 1.9 mptp? -62.6 110.72 1.8 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.821 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.711 HD11 ' HD3' ' A' ' 374' ' ' ARG . 36.6 mt -145.03 115.61 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.168 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 t -40.48 115.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.612 0.72 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 5.51 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 0.0 112.322 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -108.26 -54.82 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 382' ' ' ALA . 22.5 p -118.16 23.76 11.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.607 ' HA ' HG22 ' A' ' 376' ' ' ILE . 59.5 m-20 34.86 34.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.711 ' HB2' ' SG ' ' A' ' 380' ' ' CYS . . . -60.3 133.22 55.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -95.92 119.1 33.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . 0.661 ' CD1' ' HB1' ' A' ' 389' ' ' ALA . 37.7 m-85 -126.19 165.72 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -109.37 -48.15 3.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.42 161.04 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 388' ' ' GLU . 9.3 m -67.87 -61.35 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.155 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 387' ' ' THR . 13.7 pt-20 -34.98 -34.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.661 ' HB1' ' CD1' ' A' ' 384' ' ' PHE . . . -61.95 -55.24 31.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 20.1 mt -64.83 -43.64 92.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.423 ' HG3' HG22 ' A' ' 387' ' ' THR . 27.8 mtp180 -47.59 -55.13 9.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -72.84 -59.57 4.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.476 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -42.92 -45.09 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.784 0.326 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.43 -46.97 71.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' CYS . . . . . . . . . . . . . 52.8 t -44.3 -49.36 9.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -82.53 -46.81 12.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' CYS . . . . . . . . . . . . . 3.7 t -53.4 -63.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' CYS . . . . . . . . . . . . . 3.5 t -132.37 82.93 56.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.62 0.724 . . . . 0.0 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -20.16 35.19 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -58.36 -57.02 14.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.813 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' MET . . . . . . . . . . . . . 83.5 mmm -67.24 -56.55 9.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 96.9 t -47.37 -48.41 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -128.99 106.47 8.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.579 ' CD2' ' HG3' ' A' ' 405' ' ' GLN . 27.5 t80 -47.12 -56.39 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.888 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLN . . . . . 0.579 ' HG3' ' CD2' ' A' ' 404' ' ' TYR . 57.5 mt-30 -125.73 83.16 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 67.6 p -87.91 -48.13 8.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 408' ' ' PRO . . . 66.14 170.89 3.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.482 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' PRO . . . . . 0.439 ' C ' ' HA2' ' A' ' 407' ' ' GLY . 53.8 Cg_endo -69.81 176.96 30.66 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 -1.811 . . . . 0.0 112.336 0.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.6 m -91.89 -60.73 1.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 50.7 m -156.32 170.14 22.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.464 179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_